Treatment for eosinophilic esophagitis often involves collaboration between specialists, but patients face challenges in ...

Adolescents and adults with eosinophilic esophagitis improved with dupilumab regardless of whether they were practicing food ...

In the next in our series on rare conditions that GPs might only encounter once in a career, Dr James Chambers discusses this ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build up in the esophagus, the tube that moves food and liquids from the throat to the stomach. This buildup of ...

Eosinophilic esophagitis (EoE) is an emerging chronic food allergy disease that affects the esophagus. We use cookies to deliver the best possible experience on our website. To learn more, visit our ...

A molecular basis for milk allergen immune recognition in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology , 2025; DOI: 10.1016/j.jaci.2025.01.008 Cite This Page : ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

today announced additional positive clinical data from its ongoing RESOLVE Phase 1b/2a trial evaluating EP-104GI for the treatment of eosinophilic esophagitis ("EoE"). EoE is an inflammatory ...

Eupraxia Pharmaceuticals shares rose in premarket trading Tuesday after the company said it received positive data from its eosinophilic esophagitis treatment trials. Shares traded nearly 6.3% higher ...